SCHEMBL4773340

SCHEMBL4773340

O=C(c1ccc(-c2cc3c(Nc4cccc(Cl)c4)ncnc3[nH]2)cc1)N1CCOCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
RIPK1 Q13546 1/20 0.53
CNR1 P21554 3/20 0.52
CNR2 P34972 3/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
TBK1 Q9UHD2 3/20 0.49
PIK3CD O00329 2/20 0.49
PIK3R1 P27986 2/20 0.49
CYP1A2 P05177 1/20 0.49
ABL1 P00519 1/20 0.49
BCR P11274 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769173 0.90 RIPK1 (0.53) RIPK1CNR1CNR2CYP3A4CYP2D6
Methylpiperazine SCHEMBL4771183 0.86 RIPK1 (0.49) RIPK1TBK1ABL1BCRBRAF
SCHEMBL20150991 0.86 EGFR (0.53) RIPK1TBK1PIK3CDPIK3R1BTK
SCHEMBL4540316 0.85 CNR1 (0.57) NPC1ALDH1A1LMNAMAPTHPGD
SCHEMBL7492081 0.83 EGFR (0.58) ABL1BRAFTNNI3KEGFRCSF1R
SCHEMBL4774356 0.83 CSF1R (0.65) NPC1ALDH1A1LMNASMN1; SMN2ABL1
SCHEMBL4067498 0.82 RIPK1 (0.59) RIPK1TBK1BTKEGFRCSF1R
Hydrochloric Acid SCHEMBL4765807 0.82 CSF1R (0.64) NPC1ALDH1A1LMNASMN1; SMN2ABL1
SCHEMBL7497707 0.81 BRAF (0.54) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL4764864 0.80 CSF1R (0.46) ABL1BRAFTNNI3KEGFRCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938486-B1 SUBSTITUTED PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2008-01-16 EP claimed
US-6180636-B1 USED TO INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR THE EPIDERMAL GROWTH FACTOR AND C-ERBB2 KINASE AND CAN BE USED AS ANTITUMOR AGENTS NOVARTIS AG (CH) 2001-01-30 US claimed
EP-0938486-A1 SUBSTITUTED PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION Novartis AG (CH) 1999-09-01 EP claimed
WO-1998007726-A1 SUBSTITUTED PYRROLOPYRIMIDINES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-02-26 WO claimed